Inventia

Sustainable Development Goals

Challenges

Reach Humanity Scale Healthcare

Team

Mike Nicholls

Co-Investors

Company Briefing

Inventia Life Science is developing the Rastrum 3D Bio Printer. The Rastrum 3D Bioprinter can print human cells and bioinks into complex celluar structures that mimick tissue in the human body.

Their initial market is researchers working on high volume testing of cancer drug efficacy and other therapuetics but eventually they aim to print human skin and organoids.

Website

Related companies